One person, 5 protocols, nobody to compare against
What I ran, and what I am running now
Every other page on this site reads someone else’s evidence. This one is mine. 5 protocols over fourteen months, transcribed from my notebook with the dates on them, the doses I actually drew, and the diet, fasting and training they were attached to, plus the one I am on today. I am publishing it because I ask every vendor and every study on this site to show its working, and it would be cowardly not to show my own.
It is not a plan for you to copy, and the reason is arithmetic rather than modesty. I changed what I injected, what I ate, when I ate it and how I trained in the same weeks, and I was treated for medically low testosterone in the middle of it. Nothing here can tell you which part did what. Read it as a record of one man’s decisions, not a result.
The current one is here for a different reason. Publishing only finished protocols lets the author choose which ones to show. This one has not happened yet: I fly to Morocco on 7 October 2026 to run marathon des sables, 120 km over 5 days, sahara, self supported with a pack, and whatever happens there happens to a plan that was already public.
Aaron Cuha. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

The part of that picture nobody can see
In the middle of it I tore my bicep tendon at the elbow
Surgery was on 26 May 2026. It put my left arm in a cast for two weeks and a brace for four more, it cost me two Ironman events I had already entered, and it stopped every upper body lift I was doing. Sixteen weeks on I still have not loaded that arm, and I will not until after 20 October.
It is the most useful thing in this notebook and I nearly left it out. Every protocol before it was a choice. This one was a constraint, applied by an event nobody scheduled, and it forced a plan built entirely around losing fat to reverse itself. Calories went up. The GLP dose fell from 30 to 40 units to 0.25 mg a week. The written instruction became do not try to cut fat during the healing phase, which is the opposite of every page that came before it.
It also changed what I am training for. The two races I lost were triathlons, and a triathlon needs an arm that can swim. What replaced them is a race that does not.
Two Ironman events, already entered, cancelled.
Full cast for the first two weeks, then a removable brace to week six.
No upper body loading on the left arm at all, from the operation through to at least 20 October 2026, which will be close to five months.
Fat loss stopped being the goal, in writing, for the first time since July 2025.
The thing I would point at is the date on the plan rather than the date on the injury. The whole post-operative system was written 52 days beforehand, on the afternoon of 4 April 2026, across four notebook pages timestamped between 12:44 and 1:47 PM. I did not wake up in a cast and improvise. I sat down for about an hour, nearly two months ahead, and wrote the whole thing while I could still use both arms. That is the part of this I would actually defend, and it has nothing to do with what was in any of the syringes.
2 of the 24 compounds I took have never been given to a human being in a published study
Not “the evidence is early”. No study in people of any kind. Every compound below carries the evidence band this site works out from the studies and people it counts. It is the same band you would see anywhere else here. I did not soften it for my own page.
- AOD-9604Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.5 reported1 completed trial, none stating how many people
- ARA-290Limited. People have taken it in a published study, but fewer than 100 of them. 5 completed trials, 95 people given it.7 reported5 completed trials, 95 people given it
- BPC-157Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 31 people given it.10 reported3 completed trials, 31 people given it
- CJC-1295Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.9 reported2 completed trials, none stating how many people
- DSIPLimited. People have taken it in a published study, but fewer than 100 of them. 6 completed trials, 7 people given it.8 reported6 completed trials, 7 people given it
- GLOW blendLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it.9 reported2 completed trials, 22 people given it
- GlutathioneLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 54 people given it.8 reported1 completed trial, 54 people given it
- KLOW blendLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.11 reported1 completed trial, 13 people given it
- Methylene BlueLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 26 people given it.7 reported1 completed trial, 26 people given it
- MOTS-cLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it.6 reported1 completed trial, 30 people given it
- NAD+Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.7 reported1 completed trial, none stating how many people
- PinealonLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people.6 reported2 completed trials, none stating how many people
- ElamipretideModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 487 people given it.6 reported5 completed trials, 487 people given it
- EpitalonModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it.6 reported5 completed trials, 266 people given it
- IpamorelinModerate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 157 people given it.9 reported2 completed trials, 157 people given it
- SelankModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 192 people given it.8 reported3 completed trials, 192 people given it
- SemaxModerate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 354 people given it.9 reported4 completed trials, 354 people given it
- SermorelinModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 139 people given it.8 reported3 completed trials, 139 people given it
- Testosterone cypionateModerate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it.9 reported1 completed trial, 5,246 people given it
- 5-Amino-1MQAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.6 reported2 animal studies, no human study
- SLU-PP-332Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study.8 reported2 animal studies, no human study
- IGF-1 LR3Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.8 reported1 human study where nobody was given it
- RetatrutideStrong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it.8 reported5 completed trials, 1,345 people given it
- TesamorelinStrong. At least two finished studies in people, and at least 1,000 people who took it. 8 completed trials, 1,729 people given it.10 reported8 completed trials, 1,729 people given it
Two of those rows are vendor blends, and they hide more than they show. GLOW is three peptides in one vial and KLOW is four, adding KPV, which has two animal studies and no human study of any kind. So the count of things I injected with no human evidence behind them is three, not two. And the blends themselves are worse than their parts. No study has tested either mix in people or in animals, so the band beside them describes the ingredients, not the thing in the syringe.
Some of what I injected is not on that list at all, because my own notebook records a product name and nothing else: NAD+ Blend, NAD Blend, GHRH 4x Blend. The NAD blend turned out to be seven active ingredients plus a numbing agent once I read the seller’s ingredient list, and one of them is why I changed my dosing. The GHRH blend is still unresolved. I injected it nightly for months on a rising dose, from 20 units in February to 40 by May, and I came off it without ever finding out what was in it. A blend I cannot name is a blend I cannot check, and that is my gap, not the database’s.
Part one
What I actually ran
Five dated protocols, in order, from the morning I started in July 2025 to the operation that stopped all of it in May 2026. Each one gets what I injected, what I ate alongside it, what changed from the page before, what was measured, and what it cannot tell you.
Phase 1 · July 2025
The first stack
Notebook page dated 21 July 2025. Goal: Start. Fat loss, with everything running at once.
Written four days after the morning he decided to start, and it reads like it. It is a checklist, not a plan: eleven items, each with how long to run it, and no stages. Everything starts on the same day. Testosterone is at the lowest dose it would ever be, 50 mg twice a week. The weight-loss drug is written as "GLP-3 RT". That is the seller's code for retatrutide, not a name any label uses.
What I injected and swallowed
| When | What | Dose | Evidence |
|---|---|---|---|
| On waking | SLU-PP-3327 days a week, 12 weeks | 1 capsuleoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| On waking | NAD+ Blend7 days a week | 1 ml, 100 unitsSubQ or IM | composition not recorded |
| On waking | Glow Blend5 days a week | 25 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it. |
| On waking | MOTS-cMonday, Wednesday, Friday, 12 weeks | 3.5 mg, 70 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it. |
| On waking | AOD-96047 days a week | 0.4 mg, 16 units | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| On waking | Testosterone cypionateMonday and Tuesday | 50 mg, 25 unitsIM, glute | Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it. |
| 11:00 AM, first meal | GLP-3 RT, his code for retatrutide5 days a week, 12 weeks | 2 mg, 20 unitsSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| 11:00 AM | 5-Amino-1MQ7 days a week, 12 weeks | 50 mg, 1 capsuleoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| 3:00 PM | SLU-PP-3325 days a week, 12 weeks | 1 capsuleoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| 9:00 PM, about 3 hours after dinner | Tesamorelin7 days a week, 12 weeks | 2 mg, 40 unitsSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 8 completed trials, 1,729 people given it. |
| 9:00 PM | GlutathioneMonday, Wednesday, Friday, 4 weeks | 200 mg, 100 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 54 people given it. |
| 9:00 PM, post workout | Glow Blendtwice a week | 25 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it. |
What actually happened
- 17 July 2025: 255 lb at the start.
- 15 December 2025: 189 lb and 20 percent body fat, on the day he left for Italy.
- 66 lb over about five months, about 3 lb a week on average.
This is the only phase of the three with a start weight and an end weight. It is also by far the biggest change of the three. And it is the phase where it is hardest to say what caused what, because everything changed at once. Eleven compounds started on the same day. So did a strict diet, and a training plan he was following for the first time in eighteen months. Losing 66 lb over five months is what eating a lot less for months does on its own. Nothing here separates that from the compounds sitting on top of it.
What this phase cannot tell you
Eleven things start on the same day, so nothing that followed can be credited to any one of them. The weight change is real and written down. It is also the number that least needs a peptide to explain it. The retatrutide is written under a seller's code, not a name. That is the exact naming problem this site covers on the compound pages. It means we only know what it was because the seller's label says so.
Phase 2 · December 2025
The Italy cycle
Notebook page dated 8 December 2025. Goal: Keep the plan going around travel and long work shifts
The first version built around a real life instead of a perfect day. Doses move to whatever gap the day actually has: a morning before food on some days, the 12:30 gap before work on others, and before bed on all of them. Testosterone has doubled to 100 mg twice a week. Tesamorelin has gone from every day to three days a week, and CJC-1295 with ipamorelin fills the other days. This is the page with the syringe amount table. It is the only place in the notebook where syringe units are tied to how strong the vial is.
What changed from the phase before
- Testosterone doubled, 50 mg twice a week to 100 mg twice a week.
- Tesamorelin went from every day to three days a week, with CJC-1295 and ipamorelin filling the other nights.
- Glow Blend was replaced by KLOW, which adds KPV to the same three peptides.
- Epitalon and MOTS-c were added on a fixed weekly rhythm.
- Retatrutide went from five days a week to two, at the same 2 mg.
What I injected and swallowed
| When | What | Dose | Evidence |
|---|---|---|---|
| Monday, fasted morning | Testosterone cypionate0.5 ml, 25G 1 inch needle | 100 mgIM | Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it. |
| Monday, fasted morning | Retatrutide | 2 mg, 33 unitsSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| Monday, fasted morning | NAD Blend | 1 ml, 100 unitsIM or SubQ | composition not recorded |
| Monday, fasted morning | 5-Amino-1MQ | 1 capsuleoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| Monday, fasted morning | SLU-PP-332 | 1 capsuleoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| Monday, pre-bed | Tesamorelin | 2 mg, 40 unitsSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 8 completed trials, 1,729 people given it. |
| Monday, pre-bed | KLOW Blend | 1.25 mg, 25 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it. |
| Monday, pre-bed | Epitalon | 1 to 2 mg, 20 to 40 unitsSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it. |
| Tuesday, pre-bed | CJC-1295on the days tesamorelin is not run | 100 mcg, 5 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people. |
| Tuesday, pre-bed | Ipamorelin | 200 mcg, 8 unitsSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 157 people given it. |
| Wednesday, pre-shift | MOTS-c | 3.5 mg, 70 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it. |
| Most days, pre-shift | NAD+ Pure | 1 ml, 100 unitsIM | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| Thursday, pre-shift | Testosterone cypionatethe second of two weekly injections | 100 mgIM | Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it. |
| Thursday, pre-shift | Retatrutide | 2 mg, 33 unitsSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
How the eating actually went
- The three kinds of day he later wrote up properly were already in use here. The highest carb days included wine, pasta and dessert. The middle days allowed some pasta. The lowest days were protein only.
- Four or five of the highest carb days in a normal week. That is a loose pattern, not a strict one.
- Training five days a week wherever the schedule allowed. Coaching ran 2 PM to 2 AM Italy time, so the gym often came after finishing at 2 AM.
- Around 10,000 steps a day, just walking, not a set program.
How the week was shaped
- Monday, Wednesday and Friday have tesamorelin before bed. Tuesday and Thursday have CJC-1295 with ipamorelin instead.
- Testosterone goes on Monday and Thursday, splitting the weekly total instead of taking it in one shot. He has argued for that split elsewhere. His own blood work does not test it.
- Saturday drops to half a NAD dose, and the compounds that raise growth hormone become optional. Sunday is one capsule by mouth and a rest day.
- His reason for the whole setup: work shifts, what he had on hand, the body clock, and growth hormone timing.
What actually happened
- Start of Italy, 15 December 2025: 189 lb, 20 percent body fat.
- After about 60 days: 189 lb, 20 percent body fat.
- No change either way.
Holding steady is the result here, and it matters more than it looks. This was a travel stretch on a loose diet. Wine, pasta and dessert on the highest carb days. Some pasta on the middle days. Protein only on the lowest. Four or five of the highest carb days in a normal week. He trained five days a week where the schedule allowed. That often meant the gym after finishing coaching at 2 AM local time. He walked around 10,000 steps a day. Sixty days of that brought no weight back after a 66 lb loss. This is the stage where most people gain it back.
What this phase cannot tell you
Nothing was measured here except weight and body fat, and neither moved. So this phase tells us nothing about the compounds. A schedule that holds a result is not proof the schedule held it. The training and walking alone, eating this much, would keep weight steady. The syringe amount table means someone could repeat the doses exactly, which is more than most published plans manage. But being able to repeat something is not the same as it being tested.
Phase 3 · February 2026
Losing fat while keeping muscle, down to under 10 percent
Notebook page dated 16 February 2026. Goal: A 12 to 18 week fat loss push to under 10 percent body fat, while keeping up half marathon training
The most organized of the three, and the only one written as one system instead of a list. The first line names the goal: lose fat fast, keep muscle, protect the joints, and keep up endurance. The day starts at 4:00 AM, and every shot has a fixed time slot. Diet becomes three named kinds of day with different amounts of carbs. Training becomes a seven day plan. A 36 hour fast lands every ten days by rule, not by feel. Tesamorelin is gone, replaced by something written only as "GHRH 4x Blend".
What changed from the phase before
- Tesamorelin and the CJC-1295 with ipamorelin pair both disappear. In their place is one unnamed GHRH 4x Blend at 9:30 PM, with a written plan to step up from 20 units to 25 to 30 after two to three weeks.
- AOD-9604 moves to every single morning, before food.
- Retatrutide gets a step-up range for the first time, 2 to 3 mg instead of a fixed 2 mg.
- KLOW moves from a general dose before bed to a shot around the knees after lifting.
- Epitalon and MOTS-c are not on this page at all.
- Diet and fasting stop being unwritten habits and become written systems with numbers.
What I injected and swallowed
| When | What | Dose | Evidence |
|---|---|---|---|
| 4:35 AM, fasted | AOD-9604every day | 12 to 16 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| 4:35 AM | NAD+ Pure or NAD Blendwhich one depends on the day | 1 ml, 200 mg for the PureIM | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| 4:35 AM | SLU-PP-332 | 250 mcgoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| 4:35 AM | 5-Amino-1MQ | 50 mgoral | Animal or lab only. Only animal or lab studies on this page. No study in people yet. 2 animal studies, no human study. |
| 4:35 AM | Testosterone cypionateMonday and Thursday only | 100 mgIM | Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it. |
| 11:30 AM, before lunch | RetatrutideMonday and Thursday | 20 to 30 units, 2 to 3 mg depending on titrationSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| After the afternoon lift | KLOWinjected around the knees | 25 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it. |
| 9:30 PM, fasted | GHRH 4x Blendcomposition not recorded in the notebook | 20 units, rising to 25 to 30 after 2 to 3 weeksSubQ | composition not recorded |
The day
- 4:00 AM wake up, water with sea salt, lemon and methylene blue.
- 4:05 to 4:10 AM cold plunge, 3 to 5 minutes.
- 4:15 to 4:35 AM sauna, 20 minutes.
- 4:50 AM mobility, 5:00 to 5:45 AM run.
- 8:30 to 9:00 AM coffee, on purpose at least 90 minutes after waking.
- First meal 9:30 to 10:30 AM. Last bite 6:30 PM. Growth hormone compound 7:45 to 9:30 PM. In bed 8:00 PM.
Three kinds of day, same protein
- GREEN: 225 g carbs, 200 g protein, 110 g fat. Four meals at 9:30, 12:30, 15:30 and 18:00.
- YELLOW: 150 g carbs, 200 g protein, 110 g fat.
- RED: 50 g carbs, 200 g protein, 125 g fat. Meals shift later, 10:00 to 18:00.
- Protein stays at 200 g on every kind of day. Only carbs change, and fat goes up a little to make up for it.
- His reason for four meals instead of two: last food 90 minutes before the night growth hormone release, carbs eaten earlier and away from bedtime, and sleep protected. He calls the result a 14 hour stretch without food and says that is enough.
The 36 hour fast, every 10 days
- Finish dinner 6:30 PM, fast the whole of the next day, break it at 6:30 or 9:30 AM the morning after.
- Placed after a Yellow or Green day. Never before a heavy lift or a long run.
- The fast day becomes a Red day with zero carbs. A light walk, stretching, and easy steady cardio for 30 minutes at most are allowed. Heavy lifting, hard intervals and long runs are not.
- He does not cut food on other days to make up for it, on purpose. His reasoning: the fast removes 2,200 to 2,500 calories. Spread over ten days, that is an extra 220 to 250 fewer a day. Cutting daily calories on top of that would wreck his training.
- Breaking it: 40 to 50 g protein, 40 to 60 g carbs, low fat, then a normal meal 3 to 4 hours later. No amino acid drinks (BCAAs) during the fast. Water, salts (electrolytes) and black coffee only.
The training week
- Monday: easy steady run 30 to 45 minutes in the morning, heavy leg lift late afternoon.
- Tuesday: hard intervals or a fast steady run, and optional light kettlebell or extra small lifts in the evening.
- Wednesday: easy steady run.
- Thursday: hill sprints or intervals, and an optional short upper body lift.
- Friday: run in the morning, upper body muscle building in the afternoon.
- Saturday: long run, then small lifts or kettlebells early afternoon. No growth hormone compound.
- Sunday: stretching or a light walk. No growth hormone compound.
No outcome was recorded for this phase. That is a gap in the notebook, not a result.
What this phase cannot tell you
This is a plan, dated at its start, and no result is attached to it. It aims for under 10 percent in 12 to 18 weeks. It expects 1.2 to 1.5 lb of fat lost a week, starting from about 17 percent. That is a guess about the future, not a measurement. The GHRH 4x Blend is the biggest single gap. It is injected every night and stepped up on a schedule, but the notebook never says what is in it. So it cannot be tied to a compound page or an evidence rating.
Phase 4 · May 2026
The binder sheet, seventeen days before it all stopped
Notebook page dated 9 May 2026. Goal: Keep losing fat, on a sheet small enough to carry
A printed page for his binder, headed "shots only, by day and time". It is the plainest thing in the notebook, and the one he actually carried. No diet, no training, no reasons. Just seven days with the shots under each one and a color beside it. It is also the peak of the whole climb in doses. Retatrutide is at 30 units with a written step to 40 in week two. The unnamed nightly blend is at 40 units. That is double where February started it, and above the top of February's own step-up plan. Seventeen days after he wrote this, he was in surgery. Nothing on the page sees that coming.
What changed from the phase before
- Retatrutide is written in syringe units instead of milligrams for the first time, at 30 rising to 40. How strong the vial is does not appear on the sheet, so the sheet alone cannot tell you the dose.
- The unnamed nightly 4x blend doubles, from 20 units in February to 40. That is past the top of the step-up plan February had written for it.
- Epitalon and MOTS-c come back after being absent from the February page.
- SLU-PP-332 and 5-Amino-1MQ, the two pills he had taken since the first day in July 2025, are not on this sheet.
- Testosterone is not on it either. That is a gap in a sheet that claims to list every shot.
- Everything that was not a shot is gone: the kinds of day, the fasting rule, the training plan. This is the version stripped down to what he had to do, not what he had decided.
What I injected and swallowed
| When | What | Dose | Evidence |
|---|---|---|---|
| AM fasted, every day | AOD-9604 | 16 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| AM fasted, every day | KLOWplus 15 to 25 units after a hard workout | 25 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it. |
| AM fasted, Monday and Thursday | MOTS-c | 50 unitsSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it. |
| Mid morning, after food, seated | NAD+the seated instruction is his own, and it is there because IM NAD drops blood pressure | 0.5 ml, 100 mg on easy days; 0.75 ml, 150 mg on coaching daysIM | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| 30 to 60 minutes before lunch, Monday and Thursday | Retatrutide | 30 units, rising to 40 in week 2SubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| Pre-bed, every day | Epitalon | 50 unitsSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it. |
| Bedtime, fasted, Monday to Friday | GHRH 4x Blendstill no composition recorded, and now at double the units of February | 40 unitsSubQ | composition not recorded |
The one instruction on the page that is not a dose
- "4x blend nights need a real fasted window. Since you eat last meal 5 to 6 pm and sleep 8:30 to 9, keep dinner lower fat on 4x nights so gastric emptying does not lag from retatrutide."
- That is the only sentence on the sheet, and it is a good one. It is the only place in the whole notebook where he writes down that one drug is getting in the way of the timing of another.
- Saturday and Sunday drop the 4x blend completely. Tuesday, Wednesday and Thursday are marked as coaching days and get the higher NAD dose.
No outcome was recorded for this phase. That is a gap in the notebook, not a result.
What this phase cannot tell you
It records no diet, no training, no body weight and no result, so there is nothing here to credit anything to. Two things on it are worth a warning, not praise. The nightly blend is still unnamed and is now at 40 units. That is more of something he cannot identify, not less. And a shots list with no testosterone on it means either testosterone stopped or the list is not complete. The notebook does not say which. This is the last plan before the injury, and it is the thinnest record of the five.
Phase 5 · May to July 2026
The repair, when the plan stopped being about fat
Notebook page dated 26 May 2026, surgery. Goal: Heal a biceps tendon that was repaired by surgery at the elbow, and lose as little muscle as possible doing it
This is where everything flips. A torn biceps tendon at the elbow put the left arm in a cast for two weeks and a brace for four more. The plan written to strip fat now had to do the opposite. What stands out is when he wrote it. This phase has four pages: the peptide schedule, the rehab plan, the muscle stimulator settings and the meal plan. All four carry times from one Saturday afternoon, between 12:44 and 1:47 PM, fifty two days before the operation. He did not make this up after waking in a cast. He sat down for about an hour, weeks ahead, and wrote the whole thing while he could still use both arms.
What changed from the phase before
- The goal flips. Fat loss stops being the aim and healing replaces it, in writing.
- Retatrutide falls from 30 to 40 units to 0.25 mg a week, and does not restart until week 2.
- Calories go up, not down, to 2,400 to 2,700, with carbs kept high on purpose.
- The unnamed GHRH 4x Blend disappears after four months. CJC-1295 with ipamorelin replaces it at doses written in micrograms, then tesamorelin once the brace comes off.
- IGF-1 LR3 appears for the first and only time in the whole notebook, timed for right after electrical stimulation.
- SS-31 and BPC-157 appear for the first time. AOD-9604 and epitalon come off.
- Upper body lifting stops completely on the left and goes heavy on the right.
What I injected and swallowed
| When | What | Dose | Evidence |
|---|---|---|---|
| 3:45 AM, fasted, weeks 0 to 2 | CJC-1295 | 150 mcgSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people. |
| 3:45 AM, fasted, weeks 0 to 2 | Ipamorelin | 150 mcgSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 157 people given it. |
| 3:45 AM, fasted | SS-31, elamipretide | 2 mg | Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 487 people given it. |
| 3:45 AM, fasted | MOTS-c2 to 3 times a week | 5 mg | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it. |
| 5:10 AM, first meal after training | KLOW | not recorded on this pageSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it. |
| 5:10 AM, first meal | BPC-157written as optional | not recorded on this page | Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 31 people given it. |
| 7:00 to 7:30 PM, about 90 minutes after the last meal | CJC-1295 | 150 mcgSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people. |
| 7:00 to 7:30 PM | Ipamorelin | 150 mcgSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 157 people given it. |
| Weekly, from the start of week 2 | Retatrutideagainst 30 to 40 units on the sheet he was carrying two weeks before the operation | 0.25 mgSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| 3:45 AM, fasted, weeks 3 to 6 | Tesamorelinreplaces the morning CJC-1295 once the brace comes off | 2 mgSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 8 completed trials, 1,729 people given it. |
| 3:45 AM, fasted, weeks 3 to 6 | Ipamorelin | 100 mcgSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 157 people given it. |
| Midday, immediately after the electrical stimulation and cuff work, weeks 3 to 6 | IGF-1 LR3the written rule is that it is only ever given after stimulation, never on its own | 20 to 30 mcg | Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it. |
Replacing the lifting you are not allowed to do
- The rehab page lays it out as a swap table. Lifting weight becomes electrical muscle stimulation. Blood flow comes from a cuff squeezed on and off, compression, and movement. The brain-to-muscle signal comes from training the other arm and picturing the injured one working. The muscle burn comes from training with a cuff that limits blood flow, once that is allowed.
- Electrical stimulation ran 45 to 60 minutes a day in the cast and 60 to 75 minutes a day in the brace. It was split across the left chest, the left front shoulder and, carefully, the left biceps.
- Where the pads went was the safety rule. Both pads sat on the upper half of the biceps, on purpose away from the repaired tendon. The written reason: a tendon freshly reattached to bone is fragile, and a shocked muscle can pull on it.
- Strength was written on a 1 to 10 scale, not left to feel. Biceps: nothing at all in week 0 to 1, 4 to 6 in weeks 1 to 2, 6 to 7 in weeks 3 to 4, 7 to 9 in weeks 5 to 6. Chest and shoulder ran higher the whole time, because they were never the injury.
- A tight cuff, five minutes on and five minutes off, three to four rounds, once or twice a day, with the cuff high on the upper arm.
- Heavy, hard training on the right side four to five days a week, on his stated idea that it helps keep muscle on the left.
- Sauna 20 to 30 minutes, four to six days a week. Squeezing and cooling 20 to 30 minutes, once or twice a day.
- Stop rules, written down ahead of time: sharp pain at the tendon, a pulling feeling near the repair, or a jump in swelling after stimulation.
Eating to heal rather than to shrink
- 2,400 to 2,700 calories, described as enough to hold weight or a little more, adjusted by how active he was.
- 200 g of protein, fixed, spread across four meals. About 50 to 60 g in the meal after training and 40 to 50 g in each of the other three.
- Carbs are clearly not the enemy on this page. 180 to 250 g on leg training days, 120 to 180 g on cardio days, 80 to 120 g on rest days.
- The list of things not to do is the most specific part. Do not cut calories because the hunger is gone. Do not go low carb. Do not skip meals. Do not do hard fasts. Do not try to lose fat while healing.
- A note on what the drug does to judgement. On retatrutide he does not feel hunger, and the page says plainly that this is not permission to eat less. Eat on the schedule, not on hunger. Use shakes if the food will not go down.
- Collagen 10 to 20 g daily, salt and other electrolytes, and glycine listed as an optional extra.
Why the meals sit where they do
- His rule is that the growth hormone peptides work best when insulin is low, so meals go between the doses, not right around them.
- No food for 60 to 90 minutes before the evening peptides. No carbs right before any of them.
- Four meals a day at 5:10 AM, 9:00 AM, 1:00 PM and 5:30 PM, with the last bite at 5:30 PM and the night dose at 7:00 to 7:30 PM.
- The coaching day version of the same plan is lazier on purpose, because it had to survive a work day. A yogurt bowl with protein powder and granola every morning, the same every time. A backup rule: if the 9 AM meat is missed, it becomes two scoops of protein. Then a real lunch and a real dinner, and the kitchen closed after that.
What actually happened
- Two Ironman events, already entered, cancelled.
- No upper body lifting with the left arm from the repair through to at least October 2026.
- No body fat or muscle number was recorded at any point in this phase.
The result that matters here is not a number. He healed, kept training, and is still racing. The only honest thing to say is that a repaired tendon heals on the surgeon's timeline whether or not anything is injected next to it. What this phase can show is the decision making, and that is better than the drug choices. The whole system was written weeks ahead instead of made up on the spot. And the thing most likely to have saved muscle is the least exciting one: eating 200 g of protein a day and stimulating the muscle every single day.
What this phase cannot tell you
Nothing was measured. No weight, no body fat, no blood work, no scans, and no strength test on either arm. The strength test is the one that would have shown whether any of the swaps worked. The riskiest single item in the whole notebook is here: IGF-1 LR3. Its entire human record on this site is one study in which nobody was actually given it. Here it was injected right after stimulating a freshly repaired tendon. It is the one thing on this page I would expect a surgeon to object to, and no surgeon was asked.
The three things I did instead of lifting, and what has actually been measured for them
None of these is a compound, so none of them has a profile on this site and none of them carries an evidence band. That is a gap in the database, not a verdict. Two of the three have a better record in people than most of what I was injecting at the time.
Electrical stimulation, 45 to 75 minutes a day
This is the best supported thing I did in that phase. A review looked at ways to stop muscle wasting while a limb is out of use. It found that making the muscle contract with electrical pulses (neuromuscular electrical stimulation) raises the rate the body builds muscle, both when fasted and after meals. It can prevent or slow muscle loss during short spells of not using a limb. PubMed 28970205.
The same review contradicts the other half of my plan. Eating more protein than usual does not prevent muscle loss while a limb is out of use, in otherwise healthy people. I held 200 g a day through the whole thing on the assumption that more protein protected the arm. On the evidence, the stimulation was doing that work and the extra protein was along for the ride.
Training the other arm heavy, four to five days a week
My notes call this CNS crossover, meaning the nervous system carries training over to the other side, and treat it as obvious. It is real, and it has a number on it. A review that pooled 31 studies and 785 people found that training one limb made the untrained limb on the other side 11.9 percent stronger. The likely true figure was somewhere from 9.1 to 14.8 percent. For arms alone it was 9.4 percent. Eccentric training, where the muscle works while it lengthens, gave the biggest effect, at 17.7 percent. PubMed 28936703.
Two honest caveats. The authors say the studies they pooled had a high risk of bias, meaning the way they were run could have skewed the results. And those studies measured strength gained in a healthy, untrained limb. They did not measure strength kept in a limb held still after surgery, which is what I was asking it to do.
A blood flow cuff, compression and cooling
Blood flow restriction, a tight cuff that limits blood flow to the limb, is a busy research area after surgery. There are real rehab studies, mostly on knees, not elbows. I am not going to sum up a whole field based on my own use of it, and this site has no page for it yet. So the honest statement is this: I used it, I cannot tell you what it did, and the elbow evidence is thinner than the knee evidence I was reasoning from.
The thing I would change: I never tested either arm. No grip strength, no range of motion figures, nothing. Six weeks of daily electrical stimulation and heavy training on the other arm, and the one measurement that would have told me whether any of it worked is the one I did not take.
What was actually measured
Numbers from my own scans and lab reports, transcribed. The reports themselves carry a medical record number, a date of birth and a home address, and none of that is on this site: a record number next to a date of birth is how somebody else gets into your medical records, and it cannot be unpublished. The values are mine to show. The identifiers are not.
Body composition, including the part going the wrong way
| Date | Weight | Body fat | How it was measured |
|---|---|---|---|
| 7 October 2024 | 228.9 lb | 32.1 percent | InBody 770 bioimpedance scanNine months before he started. Skeletal muscle mass 88.2 lb, body fat mass 73.5 lb, BMI 33.8, visceral fat level 15, visceral fat area 158.4 cm2. |
| 17 July 2025 | 255 lb | 37 percent | His own record of the day he started26 lb heavier than the scan nine months earlier. This is the start of the first stack. |
| 15 December 2025 | 189 lb | 20 percent | His own record, the day he left for Italy66 lb below the start, after about five months on the first stack. |
| Mid February 2026 | 189 lb | 20 percent | His own record, after about 60 days in ItalyUnchanged over the Italy cycle. Held rather than lost, on a diet that included wine, pasta and dessert on the highest carbohydrate days. |
| September 2026 | 175 lb | 13 percent | DEXA80 lb below the July 2025 start and 24 points of body fat below it. Visceral fat mass 0.53 lb against 19 lb at the start. This point sits about four months after a surgically repaired bicep tendon and a phase where the written instruction was to stop cutting, and he describes himself as still working the figure down. |
Deep belly fat (visceral fat), on two different scales
| Date | Value | Machine | Note |
|---|---|---|---|
| 7 October 2024 | Level 15, area 158.4 cm2 | InBody 770 bioimpedance | A level and an area, on the InBody scale. Not comparable to a mass in pounds. |
| July 2025 | 19 lb | DEXA | Visceral fat mass at the start of the first stack. |
| September 2026 | 0.53 lb | DEXA | The largest proportional change in the whole record. Visceral fat is the fat around the organs and the compartment most closely tied to metabolic risk, which is why it is worth showing separately from total body fat. |
The 2024 row cannot be compared with the two below it. A bioimpedance score (from a scale that passes a tiny current through you) and a DEXA reading in pounds (from an X-ray body scan) are different measurements on different scales. Putting them in one column would show a change that neither machine measured.
The October 2024 scan is the one I would rather leave out. It is nine months before I started and it puts me 26 lb lighter than the day I began. I was not holding steady and then deciding to fix things. I was getting worse, and it was measured at the time.
Bloodwork: February 2025 before anything, August 2025 four weeks in
The largest change in the file, and the one with the clearest cause. It fell 66 percent in four weeks, from above the range to comfortably inside it. Lowering fasting insulin is the measured effect of a GLP-1 receptor agonist, and retatrutide was in the stack from the first day. Of everything he took, it is the compound with the most human evidence behind it. See what has actually been measured for it.
Above range to inside it, in the same four weeks and for the same reason. See what has actually been measured for it.
Went up slightly, which is the honest result and not a contradiction. HbA1c reflects roughly three months of blood sugar, so at four weeks it had not caught up with the insulin and glucose underneath it. Both draws sit in the prediabetic band.
The number that actually predicts cardiovascular events, and the worst result in the baseline file. Not retested in the August draw, so there is no after.
Double the reference ceiling. Small LDL particles were 561 against a ceiling of 142, four times over. Not retested.
The one cardiovascular number he cannot change and does not need to. Lp(a) is almost entirely genetic and his is very low. Worth stating because it is a piece of good luck rather than anything he did.
Below the bottom of the range at baseline, which is what clinically low means. The later figure is on 100 mg of testosterone cypionate a week. Starting testosterone replacement from a level that low changes body composition on its own, and that is the single largest confound on this whole page. See what has actually been measured for it.
Rising, inside the range, and the expected direction on testosterone. It is the number to keep watching rather than the number to celebrate. See what has actually been measured for it.
Above range at baseline. Not retested.
Did not move at all. In a file where the metabolic markers changed sharply, the inflammation marker sat still, and it is still above the optimal threshold.
Rose within the range. Worth a note rather than an alarm, and worth retesting.
Four of the worst numbers in the baseline, apolipoprotein B, LDL particle number, small LDL and ferritin, were never retested. They are the ones I would most want an after for and the ones I do not have. A page that showed only the markers that improved would be a different and worse page.
Screening
No cancer signal detected
The report states that in its clinical study, fewer than 2 of every 100 people with this result went on to receive a cancer diagnosis. A negative result does not rule cancer out and the test does not detect all cancers.
Adenomatous polyps found and fully removed
The pathologist reported the specimens as adenomatous, a precancerous polyp type that can raise colon cancer risk if left in place. All were removed during the procedure.
Repeat colonoscopy in 3 years, so due June 2028.
Agatston score 16
Left main 0, left anterior descending 1, left circumflex 0, right coronary 15. Between the 25th and 50th percentile for his age and sex. The radiologist recorded coronary atherosclerosis present with a mild plaque burden and that significant flow-limiting disease was unlikely. Taken three days before he started.
The same scan carried a non-cardiac finding: probable asymmetric gynecomastia, with a small right subareolar mass recorded as felt less likely but not excluded, and a note to correlate with history and exam. That correlation had not been done at the time of writing and is being arranged.
The blend I stopped taking daily, and why
My notebook called this “NAD Blend” and left it there. It ran on most days across all three phases. It is not NAD. It is seven active ingredients and a numbing agent, and it is mostly carnitine by weight. I only worked out what was in it when I went looking to write this page.
NAD+ / Carnitine Based Amino Blend, 20 ml glass vial. Per 1 ml, drawn as 100 units on a U-100 syringe:
| Ingredient | Per ml | What it is |
|---|---|---|
| NAD+ | 20 mg | The compound the blend is named after. By weight, it is the smallest active ingredient after the B vitamins. |
| L-Carnitine | 250 mg | By far the biggest ingredient. By weight, the blend is mostly carnitine, not NAD. |
| Methylcobalamin, vitamin B12 | 500 mcg | Extra B12 is mostly passed out in urine. A high blood level from supplements is common and usually harmless. |
| Pyridoxine, vitamin B6 | 25 mg | The one ingredient here that becomes harmful at higher doses. Too much B6 damages the nerves in the hands and feet. This is many times what you need in a day, and it is injected, so none of it is lost in the gut. |
| L-Inositol | 50 mg | Sold as a fat-processing helper. Not on this site. |
| L-Choline bitartrate | 50 mg | A nutrient the body uses in many basic chemical reactions. Not on this site. |
| L-Methionine | 10 mg | An amino acid the body uses in many basic chemical reactions. Not on this site. |
| Lidocaine 1.5 percent | carrier | A numbing drug, about 15 mg in a 1 ml dose. It is there so the shot does not sting. It is a real drug, not just filler. |
| Benzyl alcohol 0.9 percent | carrier | A preservative, the standard one used to stop germs growing in the vial. |
What the labs changed
My B vitamins came back high on my most recent test. So I cut the blend from most days to once a week, and I now take 100 mg of pure NAD on four days instead. That is the only change on this page that a blood test caused rather than a plan, and it is the one I am most glad about.
Here is what I could not see while I was taking it. The blend carries 25 mg of vitamin B6 per millilitre. On the days I ran it, that was 25 mg injected, which skips the gut entirely. The amount people need from food is a few milligrams a day. B6 is the one ingredient in there that turns harmful as the dose goes up. A 2025 statement from a panel of experts on its medical use says that both too little and too much can cause problems, particularly peripheral neuropathy, which is nerve damage. It works out that B6 takes 20 to 40 days to clear completely. PubMed 40395441.
B12 and B6 are not the same problem. Extra B12 mostly leaves the body, and a high reading is usually nothing to worry about. Extra B6 is the one linked to nerve damage. A test that says “B vitamins high” without saying which one does not tell you which of those you are in, and that is the next thing I am finding out.
The general point is bigger than this vial. Two of the things I injected are still recorded in my own notes as a product name and nothing else, including one I took nightly on a rising dose. I could not have found this without reading the seller’s ingredient list, and there was no ingredient list in my notebook at all.
Part two
What I am running now
Dated 18 September 2026, with 19 days at home, then a 10 October to 20 October travel and race window. The race is Marathon des Sables, 120 km over 5 days, Sahara, self supported with a pack. The goal, written at the top of the page, is to arrive able to walk and run day after day in the heat with a pack, not arrive lighter.
This one is different from the five above it in a way worth naming. It has no outcome because it has not happened. Everything in part one is a page I chose to publish after I knew how it went. This is the page I am publishing before I know, which is the only version of this exercise that costs me anything.
What came off, which is the actual change
Every protocol on this page until now got longer than the one before it. This one is shorter. Nineteen days out from a race, the list of things I stopped matters more than the list of things I kept.
- Tesamorelin and ipamorelinoff, and they had been the backbone of two earlier phases
- Injectable GHK-Cuoff as a shot. A serum on the skin stays
- AOD-9604, 5-Amino-1MQ and SLU-PP-332held back unless fat loss fully stalls and energy is still high
Retatrutide stays, but as maintenance at 3 mg a week split across two shots, for appetite control rather than cutting, with an instruction not to raise it before the race. That instruction is the whole shift on this page: at 175 lb and 13 percent, being 2 lb lighter is worth less than being able to eat enough to hike.
What I am injecting and swallowing
| When | What | Dose | Evidence |
|---|---|---|---|
| Weekly, split as 1.5 mg twice | Retatrutidea holding dose, for appetite control, not for losing fat. The written rule is not to raise it before the race. | 3 mg a weekSubQ | Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,345 people given it. |
| AM, training days | KLOWrepair and inflammation. The written rule is not to increase it. | 25 units, 5 days a weekSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it. |
| AM | NAD+replaced the daily NAD blend after the B vitamin blood test result | 100 mg on four daysIM | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people. |
| AM | ARA-290 | not recorded on this pageSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 5 completed trials, 95 people given it. |
| AM, mid week, only if currently cycling | MOTS-c | not recorded on this pageSubQ | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 30 people given it. |
| AM only, never at night | Selankdaytime focus | 10 mg in a combined 10/10 vial with semax | Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 192 people given it. |
| AM only, never at night | Semax | 10 mg in the same vial | Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 354 people given it. |
| Night, 3 or more hours after food, or AM fasted if dinner ran late | Sermorelinthe one compound on the page with its own mixing math written beside it | 200 mcg, 8 units at 2.5 mg/mlSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 139 people given it. |
| Evening, short cycle | Epithalon | conservative, not a large nightly milligram figureSubQ | Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 266 people given it. |
| Evening, optional, only on a short cycle | Pinealon | not recorded on this page | Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, none stating how many people. |
| Night, rescue only, not nightly | DSIPsleep rescue | not recorded on this page | Limited. People have taken it in a published study, but fewer than 100 of them. 6 completed trials, 7 people given it. |
| Morning, 3 to 5 days a week, after the peptides and before any coffee | Methylene bluetaken in water with sea salt and lemon | not recorded on this pageoral | Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 26 people given it. |
Several doses on this sheet are written as a role and a time rather than a milligram figure, and I have transcribed them that way rather than inventing the number. Where the notebook says “AM” and nothing else, that is what it says.
The training, which is the actual protocol
- 45 minutes on a treadmill or a hill every day wearing a 40 lb weighted vest. The vest goes on for all cardio and all hikes. The written reason: the race pack will be lighter than the vest, so the vest is extra load on purpose.
- 15 minutes of hard treadmill running while breathing extra oxygen, every day. A second 15 minute session on days when he can still walk properly the next morning.
- A pressurized oxygen chamber three times a week.
- A minimum of 5 km of running on coaching days and 10 km on non coaching days.
- One long hike a week of 90 to 150 minutes or more, vest on, on terrain that looks like the race.
- At least two days in a row on his feet every week, because the race is day after day, not one hard day.
- Legs only, 20 to 30 minutes four or five days a week: squats holding one weight, hip bends, step ups, split squats, back lunges, calf and shin work, outer hip work, core work lying down, side planks, and carrying a weight in the good hand.
- Cold plunge, sauna, pulsed magnetic field therapy (PEMF), breathing exercises, and red and near infrared light all stay in.
- No upper body lifting of any kind until after 20 October, which will be close to five months after the repair.
- The easing off before the race is written as: keep the vest, cut the amount of training 20 to 30 percent from 4 October, and add no new hard load in the last three days.
The eating, now built around hiking rather than shrinking
- 200 g of protein on eating days, unchanged from every phase since the injury.
- Morning after work: a third of a cup of A2 yogurt, ten raspberries, a quarter cup of blueberries, a third of a cup of organic granola.
- Lunch: 8 oz of steak and half an avocado. Dinner: 8 oz of filet with asparagus, or another lean protein with a vegetable. A shake if the protein comes up short.
- The 48 hour fast is done. The written rule is no more 36 to 48 hour fasts unless a day is completely easy. That reverses the February plan, where a 36 hour fast came every ten days by rule.
- In the last five days before leaving, carbs go up around the long vest sessions so the legs feel full of fuel, not flat.
- Salt and lemon daily, and more on days with two oxygen sessions, because the vest, the sauna and the desert all make you sweat.
The order of the morning, revised
- 1. Wake about 4:00 AM. Bathroom, then water with sea salt and lemon. No food.
- 2. Morning peptides, fasted, before any coffee: KLOW 25 units on training days, NAD+, ARA-290, MOTS-c only if currently on that block, Selank and Semax from the combined 10/10 vial. Sermorelin here only if last night's dinner ran too late for a three hour gap, otherwise it stays at night. Every injection logged in units and time.
- 3. Methylene blue on 3 to 5 days a week, with the sea salt and lemon water. Still no coffee.
- 4. Breathing exercises, a medium round. Placed on purpose before the magnetic field session and the cardio, so the breathing is done while he is still calm, not after his heart rate is already up.
- 5. Pulsed magnetic field (PEMF) session, then straight to the treadmill.
- 6. The main block, with the 40 lb vest on for all of it: 45 minutes of treadmill or hill work. Inside that block, or right after the easy part, 15 minutes of hard running while breathing extra oxygen. A second 15 minute session only if he recovered well from the day before and the legs and the repaired arm are not wrecked. If the weather rules out the trail, the whole block stays on the treadmill.
- 7. Cold plunge, after the vest work, not before it, and kept short enough that he can still work the rest of the day.
- 8. Coffee. First caffeine of the day, after the peptides, the oxygen and the cold.
- 9. Breakfast: a third of a cup of A2 yogurt, ten raspberries, a quarter cup of blueberries, a third of a cup of organic granola. A protein shake later if the day is running short of 200 g.
- 10. Later in the day, not first thing: an infrared sauna with red light at 630, 660, 850 and 940 nanometres. It can wait until after work if a morning sauna would cut the vest session short. No upper body lifting at any point.
The night, kept deliberately separate
- Sermorelin, if it has been three hours or more since the last food. If not, it moves to the next morning before food instead of being skipped.
- Epithalon, with pinealon optional, only while he is on that short cycle.
- DSIP only if sleep is actually failing. It is written as a rescue, not a nightly dose. It is the only compound on the page with that rule.
- In bed about 9:30 PM, up about 4:00 AM.
What I write down every day
- Body weight
- Biceps pain, scored 1 to 10
- Vest sessions completed
- Oxygen therapy sessions, and whether the second one happened
- 200 g of protein hit, or a written miss
- Feet checked every night
- Every injection logged in units and time
What to drop when the day falls apart
This is the part of the page I would actually hand to someone else, and it is the only place in ten months of notebooks where I wrote down what to cut. Every other protocol here assumes every day goes to plan, which is how a protocol gets abandoned whole instead of trimmed. The order is decided in advance, while I am calm, so it is not a decision I make at four in the morning on a bad one.
- Never cut
- 45 minutes in the vest, 15 minutes of oxygen therapy, and the water with salt
- Cut first
- The second oxygen session, the sauna, and any extra breathing rounds
- Do not skip
- The peptides planned for that morning, and the protein later in the day
Note what survives and what does not. The vest, the oxygen and the salt are protected. The sauna is expendable. Nothing in the injection list is on the cut list at all, which is a statement about how I rank these things and not a statement about which of them the evidence supports.
The sauna is the part I am least sure about
My plan treats sauna after training as a way to get ready for the heat of the Sahara. The research on that is weaker than I assumed. A 2025 review pooled ten studies in 199 people. It looked only at heat after exercise, meaning a sauna or a hot bath after training, compared with the same training without it. The effect on performance in hot weather was tiny: 1.04 times the no-heat result, where 1.0 means no difference, and the true figure could be anywhere from 0.94 to 1.15. The authors rated their confidence in that as low to very low. Sweat rate, heart rate and core temperature moved a little. Performance in the heat did not. PubMed 39762944.
The difference that matters is sitting in heat versus training in it. The same review notes that exercising in the heat can improve performance. It is training cool and adding the heat afterwards that showed almost nothing. If I want my body to actually adapt, not just a ritual, the change is to do some of the vest work hot instead of sitting in the sauna after it. I am keeping the sauna anyway, because I sleep better on days I use it.
Two things moved in the day, and one of them matters
- The cold plunge was at 4:05 AM in February, before training. It now comes after the vest workout.
- The sauna was at 4:15 AM in February, 20 minutes, before the run. It is now later in the day and may wait until after work.
Moving the plunge after training is the one to think about. In a 12 week study, 21 men lifted weights twice a week. After every session, one group sat in cold water for 10 minutes and the other did an easy active cool-down. Strength and muscle grew more in the cool-down group. In that group, the fast-twitch muscle fibres got 17 percent thicker, and the number of nuclei in each fibre rose 26 percent. In the cold group, neither went up. The authors end by saying people should rethink cold water as a regular recovery habit after exercise. PubMed 26174323.
How much that applies to me depends on what the plunge follows. That study was weight training with the cold right after it. A 2026 review that pooled 87 studies and 2,313 people found the same pattern for weight training. There, simply resting afterwards came out best for strength, and the authors were moderately sure of it. For endurance it was much less clear. The effect on endurance fitness was a score of 0.17, and the true figure could be anywhere from minus 0.71 to 1.05. The authors rated their confidence as low. PubMed 41845491.
So the readable version: my plunge follows the vest and oxygen block, which is endurance work, and there the evidence is uncertain in both directions. My legs session is separate and it is the one I am relying on to hold muscle while I cannot lift upper body. Keeping the cold away from that session is the change the evidence actually argues for, and it is a scheduling change rather than giving anything up.
The sauna move costs nothing, for the reason in the card above. Heat after exercise already did close to nothing for performance in the heat, so shifting it to the evening does not make it worse. It also does not turn it into heat preparation.
Every lever in this plan, and where its evidence lives
Each page grades by the same printed rule, keeps animal work apart and names who paid. Several of these grade thin for the goals they are usually sold on. That is on those pages too.
- Exercise with oxygenThe 15 minute oxygen runs.
- Hyperbaric oxygenThe pressure chamber sessions.
- Red lightThe red and near infrared panel in the sauna.
- Sauna and heatThe infrared sauna, and the sperm and alcohol findings.
- Cold plungeNow after the vest work. What cold right after strength work did to gains in trials.
- PEMFThe magnetic field mat before the treadmill.
- Wim Hof breathingThe breathing rounds, and the breath-hold risk in water.
- Methylene blueThe morning dose with salt and lemon water.
- FastingFourteen protocols and what each one asks of you.
- Diet and proteinPatterns at equal calories, and how much protein.
- No seed oilsThe seed oil trials, the inflammation trials, and his own result as a first-hand report.
- TrainingMuscle, bones and training through weight loss.
- The stackEvery compound in the plan has its own profile.
What this page cannot tell you
It is a plan, not a record. Nothing here has an outcome yet, and the three highest volume items in it, the weighted vest, the oxygen therapy and the hyperbaric (pressure chamber) sessions, are not compounds. The oxygen therapy and the chamber sessions now have evidence pages of their own, exercise with oxygen and hyperbaric oxygen, and neither finds a human trial that covers a repaired tendon. Neither does PEMF, whose tendon studies are in rats. The weighted vest still has none. I am also under four months out from a tendon repair and doing a 40 lb vest every day on it, which is a loading decision about the rest of my body taken while one part of it is still healing. If any of this goes wrong, it will be on this page too.
Why “25 units” is not a dose
A unit is a volume on a syringe, not an amount of peptide. What it delivers depends entirely on how much water went into the vial. Two people drawing the same number of units from vials mixed with different amounts of water are taking different doses. Most protocols posted online give the units and leave out how strong the mix is. These are the mix strengths (concentrations) I was working from, copied from the same notebook page.
| Compound | Concentration | Dose | Draw |
|---|---|---|---|
| Retatrutide | 6 mg/ml | 2 mg | 33u |
| Tesamorelin | 5 mg/ml | 2 mg | 40u |
| CJC-1295 | 2 mg/ml | 100 mcg | 5u |
| Ipamorelin | 2.5 mg/ml | 200 mcg | 8u |
| Epitalon | 5 mg/ml | 1 to 2 mg | 20 to 40u |
| MOTS-c | 5 mg/ml | 3.5 mg | 70u |
| KLOW | 5 mg/ml | 1.25 mg | 25u |
| NAD+ Pure | 200 mg/ml | 1 ml | 100u, IM |
| NAD Blend | not recorded | 0.5 to 1 ml | 50 to 100u, IM or SubQ |
| Testosterone cypionate | 200 mg/ml | 100 mg | 0.5 ml on a 3 ml syringe, IM |
| Sermorelin | 2.5 mg/ml, from 5 mg reconstituted with 2 ml | 200 mcg | 8u, and 10u for 250 mcg, 12u for 300 mcg |
The NAD Blend row is blank on purpose. My own notebook does not record how strong it was mixed, so the unit figure beside it means nothing without the vial in front of you. The reconstitution calculator does this arithmetic for any vial.
The honest summary
255 lb at 37 percent to 175 lb at 13 percent, over fourteen months. Deep belly fat (visceral fat) 19 lb to 0.53 lb. Those are the numbers, and they are real.
Five protocols over ten months, escalating until an injury stopped them. Testosterone doubled. The growth hormone booster (a secretagogue, which prompts the body to release its own) changed five times and spent two of those phases as something my own notes cannot name. The things that stayed constant longest were the oral pair, SLU-PP-332 and 5-Amino-1MQ, and both of those are the ones with no human study behind them.
What actually changed my body composition is not knowable from this page. I was in a large calorie deficit, I was running, and I started testosterone replacement from a medically low starting level. Any one of those moves body composition on its own. The peptides sat on top of all of that.
The torn tendon is the closest thing here to a real test, and it still is not one. It forced the plan to reverse in writing, which is the most honest part of the whole notebook, and it produced no measurement at all. Six weeks of daily electrical stimulation on an arm I never once tested.
The part I would defend is the arithmetic: the draw volumes are real, the timings are real, and the fasting rule is the one piece here with a stated reason for how it works that I could check against what has actually been measured. The part I would not defend is any suggestion that this is a protocol anyone else should run. In three weeks I take the current one into the Sahara, and whatever it does there will be added to this page whether it flatters it or not.